BRIEF published on 06/10/2024 at 17:05, 2 years 2 months ago Alexi Secures $11 Million USD Series A Funding to Accelerate AI-Powered Legal Technology Innovations Innovation AI Funding Litigation LegalTech
BRIEF published on 06/10/2024 at 17:05, 2 years 2 months ago Alexi obtient un financement de série A de 11 millions de dollars américains pour accélérer les innovations technologiques juridiques basées sur l'IA Innovation Financement IA Technologie Juridique Litige
PRESS RELEASE published on 06/10/2024 at 17:00, 2 years 2 months ago Alexi Secures $11 Million USD Series A Funding to Accelerate AI-Powered Legal Technology Innovations Alexi, a Canadian legaltech company, raises $15 million CAD in Series A funding to scale its generative AI technology for law firms, with Drive Capital leading the round Series A Funding Alexi Legaltech Company Generative AI Technology Drive Capital
PRESS RELEASE published on 09/05/2023 at 18:30, 3 years ago Alexi Announces New AI Product, Furthering Its Mission of Empowering Lawyers to Know the Law With Confidence
Published on 09/08/2026 at 01:45, 5 hours 33 minutes ago Tunkillia Environmental Scoping Report Approved
Published on 09/05/2026 at 04:05, 3 days 3 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 3 days 7 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 3 days 8 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 3 days 8 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/08/2026 at 07:05, 13 minutes ago Sandoz invests in new drug substance facility in Ljubljana, Slovenia, to expand biosimilar manufacturing capacity
Published on 09/08/2026 at 07:00, 18 minutes ago Sandoz hosts Capital Markets Day and unveils Bio100 ambition – maximising Sandoz value in its golden decade for biosimilars
Published on 09/08/2026 at 07:00, 18 minutes ago Newron reports subscription for EUR 5.5 million of shares by investor group as part of up to EUR 38 million total financing to advance Phase 3 evenamide program
Published on 09/08/2026 at 06:30, 48 minutes ago Ad hoc announcement pursuant to Art. 53 LR News Release
Published on 09/08/2026 at 06:20, 57 minutes ago Guanlan AI Applications: Higher Accuracy, Lower Cost, Smarter Interaction
Published on 09/07/2026 at 19:00, 12 hours 18 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 4 septembre 2026
Published on 09/07/2026 at 19:00, 12 hours 18 minutes ago Information concerning the total number of voting rights and shares in the share capital as of September 4, 2026
Published on 09/07/2026 at 18:05, 13 hours 13 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/08/2026
Published on 09/07/2026 at 18:05, 13 hours 13 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/08/2026
